Table of Contents

1 Product Introduction and Overview

• 1.1 Product Definition
• 1.2 Product Specification
• 1.3 Global Market Overview
  • 1.3.1 Global Anti-Viral Drugs Market Status and Forecast (2016-2027)
  • 1.3.2 Global Anti-Viral Drugs Sales Value CAGR by Region
• 1.4 Market Drivers, Inhibitors
  • 1.4.1 Market Drivers
  • 1.4.2 Market Inhibitors
  • 1.4.3 COVID-19 Impact Analysis

2 Global Anti-Viral Drugs Supply by Company

• 2.1 Global Anti-Viral Drugs Sales Value by Company
• 2.2 Anti-Viral Drugs Sales Area of Main Manufacturers
• 2.3 Trend of Concentration Rate

3 Global and Regional Anti-Viral Drugs Market Status by Category

• 3.1 Anti-Viral Drugs Category Introduction
  • 3.1.1 Nucleotide Polymerase Inhibitor
  • 3.1.2 Reverse Transcriptase Inhibitor
  • 3.1.3 Protease Inhibitor
• 3.2 Global Anti-Viral Drugs Market by Category
• 3.3 North America: by Category
• 3.4 Europe: by Category
• 3.5 Asia Pacific: by Category
• 3.6 Central & South America: by Category
• 3.7 Middle East & Africa: by Category

4 Global and Regional Anti-Viral Drugs Market Status by End User/Segment

• 4.1 Anti-Viral Drugs Segment by End User/Segment
  • 4.1.1 Oral Use
  • 4.1.2 Injection Use
• 4.2 Global Anti-Viral Drugs Market by End User/Segment
• 4.3 North America: by End User/Segment
• 4.4 Europe: by End User/Segment
• 4.5 Asia Pacific: by End User/Segment
• 4.6 Central & South America: by End User/Segment
• 4.7 Middle East & Africa: by End User/Segment

5 Global Anti-Viral Drugs Market Status by Region

• 5.1 Global Anti-Viral Drugs Market by Region
• 5.2 North America Anti-Viral Drugs Market Status
• 5.3 Europe Anti-Viral Drugs Market Status
• 5.4 Asia Pacific Anti-Viral Drugs Market Status
• 5.5 Central & South America Anti-Viral Drugs Market Status
• 5.6 Middle East & Africa Anti-Viral Drugs Market Status

6 North America Anti-Viral Drugs Market Status

• 6.1 North America Anti-Viral Drugs Market by Country
• 6.2 United States
• 6.3 Canada
• 6.4 Mexico

7 Europe Anti-Viral Drugs Market Status

• 7.1 Europe Anti-Viral Drugs Market by Country
• 7.2 Germany
• 7.3 France
• 7.4 UK
• 7.5 Italy
• 7.6 Russia
• 7.7 Spain

8 Asia Pacific Anti-Viral Drugs Market Status

• 8.1 Asia Pacific Anti-Viral Drugs Market by Country
• 8.2 China
• 8.3 Japan
• 8.4 Korea
• 8.5 Southeast Asia
• 8.6 India
• 8.7 Australasia

9 Central & South America Anti-Viral Drugs Market Status

• 9.1 Central & South America Anti-Viral Drugs Market by Country
• 9.2 Brazil
• 9.3 Argentina
• 9.4 Colombia

10 Middle East & Africa Anti-Viral Drugs Market Status

• 10.1 Middle East & Africa Anti-Viral Drugs Market by Country
• 10.2 Iran
• 10.3 Israel
• 10.4 Turkey
• 10.5 South Africa
• 10.8 Saudi Arabia

11 Sales Channel, Distributors and Buyers

• 11.1 Sales Channel
  • 11.1.1 Direct Sales
  • 11.1.2 Channel Sales
• 11.2 Anti-Viral Drugs Distributors
• 11.3 Anti-Viral Drugs Buyers

12 Global Anti-Viral Drugs Market Forecast by Category and by End User/Segment

• 12.1 Global Anti-Viral Drugs Sales Value Forecast (2022-2027)
• 12.2 Global Anti-Viral Drugs Forecast by Category
• 12.3 Global Anti-Viral Drugs Forecast by End User/Segment

13 Global Anti-Viral Drugs Market Forecast by Region/Country

• 13.1 Global Anti-Viral Drugs Market Forecast by Region (2022-2027)
• 13.2 North America Market Forecast
• 13.3 Europe Market Forecast
• 13.4 Asia Pacific Market Forecast
• 13.5 Central & South America Market Forecast
• 13.6 Middle East & Africa Market Forecast

14 Key Participants Company Information

• 14.1 Johnson & Johnson
  • 14.1.1 Company Information
  • 14.1.2 Anti-Viral Drugs Product Introduction
  • 14.1.3 Johnson & Johnson Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.1.4 Contact Information
• 14.2 Pfizer
  • 14.2.1 Company Information
  • 14.2.2 Anti-Viral Drugs Product Introduction
  • 14.2.3 Pfizer Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.2.4 Contact Information
• 14.3 Roche
  • 14.3.1 Company Information
  • 14.3.2 Anti-Viral Drugs Product Introduction
  • 14.3.3 Roche Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.3.4 Contact Information
• 14.4 Novartis
  • 14.4.1 Company Information
  • 14.4.2 Anti-Viral Drugs Product Introduction
  • 14.4.3 Novartis Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.4.4 Contact Information
• 14.5 Merck & Co.
  • 14.5.1 Company Information
  • 14.5.2 Anti-Viral Drugs Product Introduction
  • 14.5.3 Merck & Co. Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.5.4 Contact Information
• 14.6 GlaxoSmithKline
  • 14.6.1 Company Information
  • 14.6.2 Anti-Viral Drugs Product Introduction
  • 14.6.3 GlaxoSmithKline Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.6.4 Contact Information
• 14.7 Sanofi
  • 14.7.1 Company Information
  • 14.7.2 Anti-Viral Drugs Product Introduction
  • 14.7.3 Sanofi Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.7.4 Contact Information
• 14.8 AbbVie
  • 14.8.1 Company Information
  • 14.8.2 Anti-Viral Drugs Product Introduction
  • 14.8.3 AbbVie Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.8.4 Contact Information
• 14.9 Takeda
  • 14.9.1 Company Information
  • 14.9.2 Anti-Viral Drugs Product Introduction
  • 14.9.3 Takeda Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.9.4 Contact Information
• 14.10 Shanghai Pharmaceuticals Holding
  • 14.10.1 Company Information
  • 14.10.2 Anti-Viral Drugs Product Introduction
  • 14.10.3 Shanghai Pharmaceuticals Holding Anti-Viral Drugs Sales Value, Gross Margin and Global Share (2019-2021)
  • 14.10.4 Contact Information
• 14.11 Yiling Pharmaceutical

15 Conclusion

Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Anti-Viral Drugs market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Anti-Viral Drugs market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Nucleotide Polymerase Inhibitor
Reverse Transcriptase Inhibitor
Protease Inhibitor

Segmented by End User/Segment
Oral Use
Injection Use

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Johnson & Johnson
Pfizer
Roche
Novartis
Merck & Co.
GlaxoSmithKline
Sanofi
AbbVie
Takeda
Shanghai Pharmaceuticals Holding
Yiling Pharmaceutical